Prediabetes: a nutraceutical from Biofarma to counteract it

Overview


Prediabetes-a-nutraceutical-from-Biofarma-to-counteract-it.png

Diabetes is a major health issue that has reached alarming levels. Biofarma Group has developed Reglicem, an innovative clinically validated nutraceutical product able to reduce IFG (fasting blood glucose) and IGT (fast glucose tolerance) values in patients with prediabetes conditions.

These effects are made possible thanks to the action of turmeric (Curcuma longa), barberry (Berberis vulgaris), banaba (Lagerstroemia speciosa), inositol, and chromium, whose effectiveness is proven and supported by scientific evidence.

This content is provided by Biofarma Group, and any views and opinions expressed do not necessarily reflect those of NutraIngredients.com

Download Now


Latest Content

Nutrigenomics: The future of healthy living?

Nutrigenomics: The future of healthy living?

Paid for and content provided by Biofarma Group

Nutrigenomics can improve traditional limitations when developing dietary supplements by targeting specific active ingredients to promote efficacy and adaptability.

Related Resources

From Biofarma a clinically tested vaginal protection

From Biofarma a clinically tested vaginal protection

Content provided by Biofarma Group

Product Brochure

Bacterial vaginosis is considered the most common cause of vaginal infection among pregnant and non-pregnant women. In this scenario, the oral intake of gut-acting probiotics is increasingly emerging as a viable option to counteract these disorders.

Healthy ageing: a food supplement from Biofarma Group

Healthy ageing: a food supplement from Biofarma Group

Content provided by Biofarma Group

White Paper

Worldwide, the percentage of people over 65 and 80 years of age is steadily increasing. However, as society continues to age, people do not necessarily enjoy excellent health: the ageing population therefore represents 'both a triumph and a challenge'...

Supplier Info Centre

Biofarma-Group.png

For more product information visit Biofarma Group.